Skip to main content

Advertisement

SpringerLink
Log in

New Cancer Pain Treatment Options

  • Other Pain (N Vadivelu and A Kaye, Section Editors)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Cancer pain is often incapacitating and discouraging to patients; is demoralizing to family members and care takers; and is taxing and difficult to subdue for the pain specialists. The consequences of implementing suboptimal treatment are far-reaching; therefore, effective treatment methods are in a great demand. The face of cancer pain management has changed in considerable ways, and interventional procedures have become an integral part of providing multimodal analgesia in cancer pain treatment. The goals of this review are to draw attention to the critical role that regional anesthetic nerve blocks and interventional pain management techniques play in treating malignancy-related pain and emphasize the benefits provided by the aforementioned treatment strategies.

Recent Findings

A large proportion of cancer patients continues to struggle with an inadequately treated pain despite a strict adherence to the WHO analgesic step ladder. The previous pain treatment algorithm has been modified to include peripheral neural blockade, neuro-destructive techniques, neuromodulatory device use, and intrathecal drug delivery systems. The accumulated evidence highlights the opioid-sparing qualities and other benefits afforded by these modalities: decreasing medication-induced side effects, reducing economic burden of poor analgesia, and overall improvement in quality of life of the patients afflicted with a painful neoplastic disease.

Summary

The rising prevalence of cancer-related pain syndromes is paralleled by an unmatched growth of innovative treatment strategies. Modified WHO analgesic ladder represents one of the greatest paradigm shifts within the domain of oncologic pain treatment. The cancer patient population requires a prompt and liberal, albeit judicious, delivery of unorthodox pain treatment options freed from the rigid bonds of conventional guidelines and standard practices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82(3):263–74.

    Article  CAS  PubMed  Google Scholar 

  2. Bruera E, Kim HN. Cancer pain. JAMA. 2003;290(18):2476–9. doi:10.1001/jama.290.18.2476.

    Article  CAS  PubMed  Google Scholar 

  3. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985–91. doi:10.1093/annonc/mdn419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64(1):107–14.

    Article  CAS  PubMed  Google Scholar 

  5. World Health Organization. Cancer pain relief. Albany, NY: WHO Publications Center.1986:1–70.

  6. Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control. 2000;7(2):149–56.

    CAS  PubMed  Google Scholar 

  7. Azevedo Sao Leao Ferreira K, Kimura M, Jacobsen Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer. 2006;14(11):1086–93. doi:10.1007/s00520-006-0086-x.

    Article  PubMed  Google Scholar 

  8. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8(2):189–98. doi:10.1111/j.1526-4637.2006.00220.x.

    Article  PubMed  Google Scholar 

  9. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56(6):514–7. e202-5.

    PubMed  PubMed Central  Google Scholar 

  10. • Kaasa S. Is cancer pain control improved by a simple WHO pain analgesic ladder approach combined with tumor-directed treatment? J Clin Oncol. 2016;34(5):399–400. doi:10.1200/JCO.2015.64.7537. The article looks at the fleeting nature of the WHO Analgesic Ladder and assesses its usefullness in managing pain in a contemporary cancer pain patient.

    Article  CAS  PubMed  Google Scholar 

  11. • Amr YM, Makharita MY. Neurolytic sympathectomy in the management of cancer pain-time effect: a prospective, randomized multicenter study. J Pain Symptom Manage. 2014;48(5):944–56 e2. doi:10.1016/j.jpainsymman.2014.01.015. The authors demonstrate an improved pain control, lower opioid requirement, and improved life quality when interventions are done early rather than as the fourth step of the WHO analgesic ladder. It supports the argument that treatment strategy and its timing should be contingent upon specific needs of the cancer patient rather than an imposed guideline.

  12. Burton AW, Hamid B. Current challenges in cancer pain management: does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther. 2007;7(11):1501–2. doi:10.1586/14737140.7.11.1501.

    Article  PubMed  Google Scholar 

  13. • Dobosz L, Stefaniak T, Dobrzycka M, Wieczorek J, Franczak P, Ptaszynska D, et al. Invasive treatment of pain associated with pancreatic cancer on different levels of WHO analgesic ladder. BMC Surg. 2016;16:20. doi:10.1186/s12893-016-0136-3. Another publication supporting an early use of invasive procedures and demonstrating improved treatment outcomes compared to a late application within the final steps of the WHO analgesic ladder.

    Article  PubMed  PubMed Central  Google Scholar 

  14. •• Klepstad P, Kurita GP, Mercadante S, Sjogren P. Evidence of peripheral nerve blocks for cancer-related pain: a systematic review. Minerva Anestesiol. 2015;81(7):789–93. A systematic review assessing the efficacy and highlighting the benefits of regional anesthesia in the management of cancer-related pain.

    CAS  PubMed  Google Scholar 

  15. •• Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12(4):213–26. doi:10.1038/nrclinonc.2014.224. An instrumental publication illustrating how the immediate post-operative period influences remission or progression of a neoplastic disease and validates the argument that an adequate yet cautiously implemented postoperative pain regimen might hasten recovery and prevent disease progression or relapse in a cancer patient.

    Article  CAS  PubMed  Google Scholar 

  16. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999;80(6):880–8.

    Article  CAS  PubMed  Google Scholar 

  17. Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol. 1998;160(7):3251–8.

    CAS  PubMed  Google Scholar 

  18. Gatti G, Cavallo R, Sartori ML, Marinone C, Angeli A. Cortisol at physiological concentrations and prostaglandin E2 are additive inhibitors of human natural killer cell activity. Immunopharmacology. 1986;11(2):119–28.

    Article  CAS  PubMed  Google Scholar 

  19. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther. 2004;11(5):354–65.

    Article  PubMed  Google Scholar 

  20. Peng J, Wang SD. Effect of anesthesia combined with intercostal nerve block on analgesia for esophageal cancer after operation. Eur Rev Med Pharmacol Sci. 2015;19(12):2293–6.

    CAS  PubMed  Google Scholar 

  21. Matchett G. Intercostal nerve block and neurolysis for intractable cancer pain. J Pain Palliat Care Pharmacother. 2016;30(2):114–7. doi:10.3109/15360288.2016.1167804.

    Article  PubMed  Google Scholar 

  22. Terkawi AS, Tsang S, Sessler DI, Terkawi RS, Nunemaker MS, Durieux ME, et al. Improving analgesic efficacy and safety of thoracic paravertebral block for breast surgery: a mixed-effects meta-analysis. Pain Physician. 2015;18(5):E757–80.

    PubMed  Google Scholar 

  23. •• Pei L, Zhou Y, Tan G, Mao F, Yang D, Guan J, et al. Ultrasound-assisted thoracic paravertebral block reduces intraoperative opioid requirement and improves analgesia after breast cancer surgery: a randomized, controlled, single-center trial. PLoS One. 2015;10(11):e0142249. doi:10.1371/journal.pone.0142249. Peripheral blocks, such as paravertebral block, allow to minimize the use of narcotic medications and to achieve a better pain control as proven in this RCT described by Pei et al.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hida K, Murata H, Sakai A, Ogami K, Maekawa T, Hara T. Perioperative pain management of minimally invasive esophagectomy with bilateral continuous thoracic paravertebral block. Masui. 2016;65(2):119–24.

    PubMed  Google Scholar 

  25. McDonnell JG, O’Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007;104(1):193–7. doi:10.1213/01.ane.0000250223.49963.0f.

    Article  PubMed  Google Scholar 

  26. Carney J, McDonnell JG, Ochana A, Bhinder R, Laffey JG. The transversus abdominis plane block provides effective postoperative analgesia in patients undergoing total abdominal hysterectomy. Anesth Analg. 2008;107(6):2056–60. doi:10.1213/ane.0b013e3181871313.

    Article  CAS  PubMed  Google Scholar 

  27. •• Zhong T, Ojha M, Bagher S, Butler K, Srinivas C, McCluskey SA, et al. Transversus abdominis plane block reduces morphine consumption in the early postoperative period following microsurgical abdominal tissue breast reconstruction: a double-blind, placebo-controlled, randomized trial. Plast Reconstr Surg. 2014;134(5):870–8. doi:10.1097/PRS.0000000000000613. This article is relevant because depicts another available technique that can be employed for postoperative pain control in cancer patients, which helps to reduce an opioid requirement and minimize the associated side effects of the medications.

  28. Milan ZB, Duncan B, Rewari V, Kocarev M, Collin R. Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients. Transplant Proc. 2011;43(7):2687–90. doi:10.1016/j.transproceed.2011.06.059.

    Article  CAS  PubMed  Google Scholar 

  29. Hebbard PD, Barrington MJ, Vasey C. Ultrasound-guided continuous oblique subcostal transversus abdominis plane blockade: description of anatomy and clinical technique. Reg Anesth Pain Med. 2010;35(5):436–41.

    Article  PubMed  Google Scholar 

  30. Wu Y, Liu F, Tang H, Wang Q, Chen L, Wu H, et al. The analgesic efficacy of subcostal transversus abdominis plane block compared with thoracic epidural analgesia and intravenous opioid analgesia after radical gastrectomy. Anesth Analg. 2013;117(2):507–13. doi:10.1213/ANE.0b013e318297fcee.

    Article  CAS  PubMed  Google Scholar 

  31. • Gebhardt R, Wu K. Transversus abdominis plane neurolysis with phenol in abdominal wall cancer pain palliation. Pain Physician. 2013;16(3):E325–30. This publication describes the use of neurolytic block which can be used to provide more sustained pain control in patients who responded positively to a block with local anesthetic.

  32. • Wisotzky EM, Saini V, Kao C. Ultrasound-guided intercostobrachial nerve block for intercostobrachial neuralgia in breast cancer patients: a case series. PM R. 2016;8(3):273–7. doi:10.1016/j.pmrj.2015.10.003. A case series documenting a successful use of a relatively new technique used for pain control in post-mastectomy patients suffering from intercostobrachial neuralgia.

    Article  PubMed  Google Scholar 

  33. • Wijayasinghe N, Duriaud HM, Kehlet H, Andersen KG. Ultrasound guided intercostobrachial nerve blockade in patients with persistent pain after breast cancer surgery: a pilot study. Pain Physician. 2016;19(2):E309–18. Additional publication describing a pilot study on intercostobrachial nerve blockade.

    PubMed  Google Scholar 

  34. •• Bashandy GM, Abbas DN. Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial. Reg Anesth Pain Med. 2015;40(1):68–74. doi:10.1097/AAP.0000000000000163. Pectoral nerve block is one of the novel techniques used for analgesia after breast surgery; the authors show a good analgesia afforded by this novel technique.

  35. • Wijayasinghe N, Andersen KG, Kehlet H. Analgesic and sensory effects of the pecs local anesthetic block in patients with persistent pain after breast cancer surgery: a pilot study. Pain Pract. 2016. doi:10.1111/papr.12423. This is relevant because it is a pilot study of the use of pectoral nerve blockade in the management of cancer-related pain syndromes.

  36. Vranken JH, van der Vegt MH, Zuurmond WW, Pijl AJ, Dzoljic M. Continuous brachial plexus block at the cervical level using a posterior approach in the management of neuropathic cancer pain. Reg Anesth Pain Med. 2001;26(6):572–5. doi:10.1053/rapm.2001.26488.

    Article  CAS  PubMed  Google Scholar 

  37. • Zinboonyahgoon N, Vlassakov K, Abrecht CR, Srinivasan S, Narang S. Brachial plexus block for cancer-related pain: a case series. Pain Physician. 2015;18(5):E917–24. The authors show a critical role of the brachial plexus block in treating neoplastic pain.

  38. Pacenta HL, Kaddoum RN, Pereiras LA, Chidiac EJ, Burgoyne LL. Continuous tunnelled femoral nerve block for palliative care of a patient with metastatic osteosarcoma. Anaesth Intensive Care. 2010;38(3):563–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. • Fujiwara S, Komasawa N, Hyoda A, Kuwamura A, Kido H, Minami T. Ultrasound-guided sciatic nerve block (pulsed radiofrequency) for intractable cancer pain caused by sacral bone metastasis. Masui. 2015;64(6):663–5. Relevant because describes the use of a less frequently encountered, but important, sciatic nerve block used to curb pain stemming from sacral bone metastasis.

    PubMed  Google Scholar 

  40. •• Candido KD KN. Neurolytic Blocks. In: Diwan S SP, editor. Atlas of pain medicine procedures. New York: MCGraw-Hill Professional Publishing; 2014. The authors offer a detailed yet concise overview of various neurolytic blocks commonly used in cancer-pain management, along with thorough descriptions of the techniques and high-quality images.

  41. •• Mercadante S, Klepstad P, Kurita GP, Sjogren P, Giarratano A, European Palliative Care Research C. Sympathetic blocks for visceral cancer pain management: a systematic review and EAPC recommendations. Crit Rev Oncol Hematol. 2015;96(3):577–83. doi:10.1016/j.critrevonc.2015.07.014. A critical publication analyzing the evidence supporting the use of sympathetic blocks in the management of oncologic pain, which also puts forward recommendations on the use of this treatment modality.

    Article  PubMed  Google Scholar 

  42. Kanpolat Y, Savas A, Bekar A, Berk C. Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1,600 patients. Neurosurgery. 2001;48(3):524–32. discussion 32–4.

    Article  CAS  PubMed  Google Scholar 

  43. Sweet WH. Controlled thermocoagulation of trigeminal ganglion and rootlets for differential destruction of pain fibers: facial pain other than trigeminal neuralgia. Clin Neurosurg. 1976;23:96–102.

    CAS  PubMed  Google Scholar 

  44. •• Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med. 2013;14(10.1111/pme.12176):1140–63. Highly relevant systematic review assessing the efficacy of celiac plexus for the treatment of abdominal malignancy-related pain.

    Article  PubMed  Google Scholar 

  45. Kaufman M, Singh G, Das S, Concha-Parra R, Erber J, Micames C, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44(2):127–34. doi:10.1097/MCG.0b013e3181bb854d.

    Article  PubMed  Google Scholar 

  46. Staats PS, Hekmat H, Sauter P, Lillemoe K. The effects of alcohol celiac plexus block, pain, and mood on longevity in patients with unresectable pancreatic cancer: a double-blind, randomized, placebo-controlled study. Pain Med. 2001;2(1):28–34. doi:10.1046/j.1526-4637.2001.002001028.x.

    Article  CAS  PubMed  Google Scholar 

  47. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP, Kinney MO, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004;291(9):1092–9. doi:10.1001/jama.291.9.1092.

    Article  CAS  PubMed  Google Scholar 

  48. Erdek MA, Halpert DE, Gonzalez Fernandez M, Cohen SP. Assessment of celiac plexus block and neurolysis outcomes and technique in the management of refractory visceral cancer pain. Pain Med. 2010;11(1):92–100. doi:10.1111/j.1526-4637.2009.00756.x.

    Article  PubMed  Google Scholar 

  49. •• Zhong W, Yu Z, Zeng JX, Lin Y, Yu T, Min XH, et al. Celiac plexus block for treatment of pain associated with pancreatic cancer: a meta-analysis. Pain Pract. 2014;14(1):43–51. doi:10.1111/papr.12083. Highly relevant meta-analysis of the efficacy of celiac plexus block which is one of the main techniques used to treat abdominal cancer pain.

    Article  PubMed  Google Scholar 

  50. Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29(26):3541–6. doi:10.1200/JCO.2010.32.2750.

    Article  PubMed  Google Scholar 

  51. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;3:CD007519. doi:10.1002/14651858.CD007519.pub2.

    Google Scholar 

  52. de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain. 2004;110(1–2):400–8. doi:10.1016/j.pain.2004.04.023.

    Article  PubMed  Google Scholar 

  53. Mishra S, Bhatnagar S, Rana SP, Khurana D, Thulkar S. Efficacy of the anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain in advanced gynecological cancer patients. Pain Med. 2013;14(6):837–42. doi:10.1111/pme.12106.

    Article  PubMed  Google Scholar 

  54. Plancarte R, de Leon-Casasola OA, El-Helaly M, Allende S, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth. 1997;22(6):562–8.

    CAS  PubMed  Google Scholar 

  55. Zechlinski JJ, Hieb RA. Lumbar sympathetic neurolysis: how to and when to use? Tech Vasc Interv Radiol. 2016;19(2):163–8. doi:10.1053/j.tvir.2016.04.008.

    Article  PubMed  Google Scholar 

  56. Gulati A, Khelemsky Y, Loh J, Puttanniah V, Malhotra V, Cubert K. The use of lumbar sympathetic blockade at L4 for management of malignancy-related bladder spasms. Pain Physician. 2011;14(3):305–10.

    PubMed  Google Scholar 

  57. • Woo JH, Park HS, Kim SC, Kim YH. The effect of lumbar sympathetic ganglion block on gynecologic cancer-related lymphedema. Pain Physician. 2013;16(4):345–52. The authors demonstrate additional benefits besides ameliorating cancer pain provided by sympathetic block, such as improving cancer-related lymphedema.

  58. Toshniwal GR, Dureja GP, Prashanth SM. Transsacrococcygeal approach to ganglion impar block for management of chronic perineal pain: a prospective observational study. Pain Physician. 2007;10(5):661–6.

    PubMed  Google Scholar 

  59. • Huang L, Tao F, Wang Z, Wan H, Qu P, Zheng H. Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain. J BUON. 2014;19(3):826–30. This article shows that it is possible to combine individual blocks to achieve better therapeutic outcomes.

  60. • Ahmed DG, Mohamed MF, Mohamed SA. Superior hypogastric plexus combined with ganglion impar neurolytic blocks for pelvic and/or perineal cancer pain relief. Pain Physician. 2015;18(1):E49–56. This article shows that it is possible to combine individual blocks to achieve better therapeutic outcomes.

  61. Candido K, Stevens RA. Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol. 2003;17(3):407–28.

    Article  PubMed  Google Scholar 

  62. Candido KD, Philip CN, Ghaly RF, Knezevic NN. Transforaminal 5% phenol neurolysis for the treatment of intractable cancer pain. Anesth Analg. 2010;110(1):216–9. doi:10.1213/ANE.0b013e3181c0ecd5.

    Article  PubMed  Google Scholar 

  63. De Pinto M, Naidu RK. Peripheral and neuraxial chemical neurolysis for the management of intractable lower extremity pain in a patient with terminal cancer. Pain Physician. 2015;18(4):E651–6.

    PubMed  Google Scholar 

  64. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971–9.

    Article  CAS  PubMed  Google Scholar 

  65. Shealy CN, Taslitz N, Mortimer JT, Becker DP. Electrical inhibition of pain: experimental evaluation. Anesth Analg. 1967;46(3):299–305.

    Article  CAS  PubMed  Google Scholar 

  66. Shealy CN, Mortimer JT, Hagfors NR. Dorsal column electroanalgesia. J Neurosurg. 1970;32(5):560–4. doi:10.3171/jns.1970.32.5.0560.

    Article  CAS  PubMed  Google Scholar 

  67. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: a systematic review. Pain Physician. 2009;12(2):379–97.

    PubMed  Google Scholar 

  68. Grabow TS, Tella PK, Raja SN. Spinal cord stimulation for complex regional pain syndrome: an evidence-based medicine review of the literature. Clin J Pain. 2003;19(6):371–83.

    Article  PubMed  Google Scholar 

  69. Simpson EL, Duenas A, Holmes MW, Papaioannou D, Chilcott J. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess. 2009;13(17):iii, ix-x, 1–154. doi:10.3310/hta13170.

  70. Viswanathan A, Phan PC, Burton AW. Use of spinal cord stimulation in the treatment of phantom limb pain: case series and review of the literature. Pain Pract. 2010;10(5):479–84. doi:10.1111/j.1533-2500.2010.00374.x.

    Article  PubMed  Google Scholar 

  71. Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg. 2002;94(3):694–700; table of contents.

  72. Taylor RS, De Vries J, Buchser E, Dejongste MJ. Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials. BMC Cardiovasc Disord. 2009;9:13. doi:10.1186/1471-2261-9-13.

    Article  PubMed  PubMed Central  Google Scholar 

  73. •• Knezevic NN, Candido KD, Rana S, Knezevic I. The use of spinal cord neuromodulation in the management of HIV-related polyneuropathy. Pain Physician. 2015;18(4):E643–50. First article describing a successful treatment of HIV-related neuropathic pain with spinal cord stimulator, which illustrates the excellent pain response that careful patients might benefit from the device and lays the groundwork for its application in treating cancer-related pain syndromes.

    PubMed  Google Scholar 

  74. •• Deer TR, Mekhail N, Provenzano D, Pope J, Krames E, Leong M et al. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014;17(6):515–50; discussion 50. doi:10.1111/ner.12208. Highly relevant review of the safety and efficacy of neuromodulation conducted by the NACC of the INS.

  75. Wininger KL, Bester ML, Deshpande KK. Spinal cord stimulation to treat postthoracotomy neuralgia: non-small-cell lung cancer: a case report. Pain Manag Nurs. 2012;13(1):52–9. doi:10.1016/j.pmn.2011.11.001.

    Article  PubMed  Google Scholar 

  76. Yakovlev AE, Resch BE, Karasev SA. Treatment of cancer-related chest wall pain using spinal cord stimulation. Am J Hosp Palliat Care. 2010;27(8):552–6. doi:10.1177/1049909110373240.

    Article  PubMed  Google Scholar 

  77. Yakovlev AE, Resch BE. Spinal cord stimulation for cancer-related low back pain. Am J Hosp Palliat Care. 2012;29(2):93–7. doi:10.1177/1049909111410414.

    Article  PubMed  Google Scholar 

  78. Nouri KH, Brish EL. Spinal cord stimulation for testicular pain. Pain Med. 2011;12(9):1435–8. doi:10.1111/j.1526-4637.2011.01210.x.

    Article  PubMed  Google Scholar 

  79. Cata JP, Cordella JV, Burton AW, Hassenbusch SJ, Weng HR, Dougherty PM. Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report. J Pain Symptom Manage. 2004;27(1):72–8.

    Article  PubMed  Google Scholar 

  80. Yakovlev AE, Ellias Y. Spinal cord stimulation as a treatment option for intractable neuropathic cancer pain. Clin Med Res. 2008;6(3–4):103–6. doi:10.3121/cmr.2008.813.

    Article  PubMed  PubMed Central  Google Scholar 

  81. •• Pope JE, Deer TR, Bruel BM, Falowski S. Clinical uses of intrathecal therapy and its placement in the pain care algorithm. Pain Pract. 2016. doi:10.1111/papr.12438. Intrathecal drug pumps are an integral part of cancer pain management. This is a highly relevant review article focusing on intrathecal pump use in patients with severe chronic cancer-related pain.

  82. Rauck RL, Cherry D, Boyer MF, Kosek P, Dunn J, Alo K. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain. 2003;4(8):441–7.

    Article  CAS  PubMed  Google Scholar 

  83. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040–9.

    Article  CAS  PubMed  Google Scholar 

  84. Siddall PJ, Molloy AR, Walker S, Mather LE, Rutkowski SB, Cousins MJ. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg. 2000;91(6):1493–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Advocate Illinois Masonic Medical Center, 836 West Wellington Avenue, Suite 4815, Chicago, IL, 60657, USA

    Kenneth D. Candido, Teresa M. Kusper & Nebojsa Nick Knezevic

  2. Department of Anesthesiology, University of Illinois Chicago, 836 West Wellington Avenue, Suite 4815, Chicago, IL, 60657, USA

    Kenneth D. Candido & Nebojsa Nick Knezevic

  3. Department of Surgery, University of Illinois Chicago, 836 West Wellington Avenue, Suite 4815, Chicago, IL, 60657, USA

    Kenneth D. Candido & Nebojsa Nick Knezevic

Authors
  1. Kenneth D. Candido
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa M. Kusper
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nebojsa Nick Knezevic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth D. Candido.

Ethics declarations

Conflict of Interest

Kenneth D. Candido, Teresa M. Kusper, and Nebojsa Nick Knezevic declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Other Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Candido, K.D., Kusper, T.M. & Knezevic, N.N. New Cancer Pain Treatment Options. Curr Pain Headache Rep 21, 12 (2017). https://doi.org/10.1007/s11916-017-0613-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-017-0613-0

Keywords

Search

Navigation